Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Brucellosis testing regime to be reduced in NI
cattle
Currently, the Brucellosis Eradication Programme costs farmers an estimated £7 million a year in compliance costs.

CVO says: "We must not relax our attitude"

Northern Ireland's testing regime for brucellosis is set to be reduced ahead of schedule.

Announcing the news, agriculture minister Michelle O'Neill said biennial herd testing for beef cattle will be introduced from next week (29 June).

Changes will be phased in over the next few months.

This is expected to bring significant benefits to farmers and taxpayers.

"I anticipate major savings for industry, taxpayers and the Department of Agriculture and Rural Development (DARD) through the gradual dismantling of the brucellosis scheme as we move forward," Ms O'Neill said.


Currently, the Brucellosis Eradication Programme costs farmers an estimated £7 million a year in compliance costs and taxpayers around £8 million a year.

Brucellosis is a highly contagious cattle disease characterised by abortions. It can be transmitted to humans, with serious consequences for human health.

It has been more than three years since the last confirmed
brucellosis case in Northern Ireland. An application for officially brucellosis free (OBF) status is currently with the EU Commission. Brucellosis testing will continue for five years after OBF status is granted.

While the reduced testing has been welcomed by the government and veterinary associations, the chief veterinary officer Robert Huey stressed the importance of continued compliance with biosecurity advice and testing measures.

"We must not relax our attitude to the reporting of abortions or any suspicion of brucellosis," he warned.

An isolated case of BSE was recently confirmed on a farm in County Louth. BVA president John Blackwell said this shows vets and farmers "need to be ever vigilant against the incursion of disease. Now is not the time to be lax in that vigilance."

BVA and BVA Northern Ireland branch said the early reduction in testing requirements is a testament to the hard work of vets and farmers.

"This has taken real and effective partnerships between vets, farmers and government," Mr Blackwell commented.

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'